TBC1D4 and colorectal cancer: Specifically, we found two phosphorylation sites related to mTOR signaling, AKT1S1-S183 and TBC1D4-S588, among the pathway markers targeted in the hybrid-DIA analysis, that were statistically down-regulated in patients with colorectal cancer relapse after surgery (Fig. 5B).